NCT06041282 Conservative Treatment of Early Adhesive Capsulitis
| NCT ID | NCT06041282 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Adhesive Capsulitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2026-01-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective, multicentre, randomized controlled study comparing the efficacy of conservative treatment for early adhesive capsulitis
Eligibility Criteria
Inclusion Criteria: * Patients in our hospital who need manual release of periarthritis of shoulder or home rehabilitation treatment; * Unilateral and primary periarthritis of shoulder * Age ≥40 years old and ≤80 years old, regardless of gender. * Forward flexion movement is more than 50% limited compared with the contralateral. * Duration of disease ≤3 months Exclusion Criteria: * Patients with a previous history of shoulder joint surgery * Patients who did not complete the follow-up within the specified time * Patients with other shoulder diseases. * Patient with systemic immune disease. * Patients who have participated in clinical trials or are conducting other clinical trials within 3 months before screening * Patients with serious primary cardiovascular diseases, lung diseases, endocrine and metabolic diseases, or serious diseases affecting their survival, such as tumor or AIDS, are considered not suitable for admission. * Patients with serious liver diseases, kidney diseases, hematological diseases, such as kidney function (BUN, Cr) more than the upper limit of normal, liver function (ALT, AST, TBIL) more than 2 times the upper limit of normal. * Patients with viral hepatitis, infectious diseases, abnormal blood coagulation mechanism and other diseases that researchers consider inappropriate for surgery. * Pregnant or lactating women, or those planning to get pregnant during the test, with positive urine HCG test results before the test; Menstruating women should wait until their period is over before undergoing surgery. * Patients with severe neurological and mental diseases. * Suspected or true history of alcohol and drug abuse.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06041282 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Adhesive Capsulitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06041282 currently recruiting?
Yes, NCT06041282 is actively recruiting participants. Contact the research team at wlshen@zju.edu.cn for enrollment information.
Where is the NCT06041282 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06041282 clinical trial?
NCT06041282 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 300 participants.